← Leaderboards
Lisa Doan
New York University School Of Medicine
$3,617,464
Attributed
$7,981,815
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2019–24$2.5M$1.9M$1.3M$625K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,981,815 · 4
By mechanism
UH3$5,247,593 · 1
UG3$1,768,147 · 2
U24$966,075 · 1
Top collaborators
- Jing Wang9 shared
- Zhe Sage Chen1 shared
- Tamas Adam Gonda1 shared
- Richard B. Lipton1 shared
- Hyung Park1 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- John P Rotrosen$35,649,271
- Jing Wang$11,467,417
- Lorna Thorpe$21,064,292
- Amanda W. Lund$5,973,567
- John A Dodson$11,071,981
Others in their field
Other Emerging Leaders on “Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Bambra Strokes · Ppd Development Lp$65,000,267
- Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
SyndromePainOpioid EpidemicSuccessChronic PainOperative Surgical ProceduresPain ManagementHospitalsUnited States National Institutes Of HealthUniversitiesPrecision MedicineChronicClinical And Translational Science AwardsCohortAcute PainSiteOpiate AddictionMoodsEfficacy TestingBrief Pain InventoryMultimodalityPostoperative PainOpioid UseAcetaminophen
Grant awards (10)
Optimizing the use of ketamine to reduce chronic postsurgical pain$866,163
UH3 · FY2024 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$474,022
UH3 · FY2024 · CA
Predictive Biosignature for Endoscopic Therapy for Chronic Pancreatitis Pain$1,244,812
UG3 · FY2023 · NS · contact PI
Optimizing the use of ketamine to reduce chronic postsurgical pain$1,206,858
UH3 · FY2023 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$1,206,858
UH3 · FY2022 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$106,127
UH3 · FY2022 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$1,281,438
UH3 · FY2021 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$106,127
UH3 · FY2021 · CA
Optimizing the use of ketamine to reduce chronic postsurgical pain$523,335
UG3 · FY2020 · CA
Early Phase Pain Investigation Clinical Network: Greater New York Clinical Center$966,075
U24 · FY2019 · NS · contact PI